ZyVersa Therapeutics Inc (ZVSA)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Nov 15, 16:00
1.06
-0.02
(-1.85%)
After-Hours: 20:00
ZyVersa Therapeutics Shareholders Equity (Quarterly): 8.620M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 8.620M |
| March 31, 2024 | 11.22M |
| December 31, 2023 | 11.07M |
| September 30, 2023 | 19.70M |
| June 30, 2023 | 20.06M |
| Date | Value |
|---|---|
| March 31, 2023 | 97.10M |
| December 31, 2022 | 99.99M |
| September 30, 2022 | -11.80M |
| June 30, 2022 | -15.22M |
| December 31, 2021 | -12.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-15.22M
Minimum
Jun 2022
99.99M
Maximum
Dec 2022
22.83M
Average
11.15M
Median
Shareholders Equity (Quarterly) Benchmarks
| NeuroBo Pharmaceuticals Inc | 12.95M |
| Dermata Therapeutics Inc | 3.318M |
| Cognition Therapeutics Inc | 23.01M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -0.1115M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.47M |
| Total Liabilities (Quarterly) | 10.85M |